In 2019, research continued to drive progress across the spectrum of cancer care in the form of new and better ways to prevent, detect, diagnose, and treat some of the many diseases we call cancer. Here’s a look at some key developments in drug approvals, precision medicine, disparities research, and immunotherapy.
Urologist Ardeshir Rastinehad, DO, is developing an alternative to standard laser therapy to help prostate cancer patients avoid side effects like urinary incontinence and erectile dysfunction.
New law mandates that cancer drugs get tested in kids in clinical trials.
Researchers are studying how best to support cancer caregivers.
Research indicates that only a small percentage of high-risk individuals eligible for lung cancer screening actually undergo a scan.
A new study explores the impact of lowering a patient's dose due to side effects.
Jocelyn Tan, MD, answers questions on research into whether the keto diet may have a role in cancer treatment.
Experts at the San Antonio Breast Cancer Symposium discussed avenues for further development following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019.
Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.
Compared with intravenous paclitaxel, the oral form of the chemotherapy drug has been associated with improved tumor shrinkage in metastatic breast cancer patients.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More